Diabetes

Cost of NHS prescribing for diabetes rises by more than £500m since 2015/2016

Prescribing costs for diabetes items rose from £960m in 2015/2016 to 1.53bn in 2022/2023.…

National patient safety alert issued for GLP-1 receptor agonists

The alert warns healthcare providers not to switch between brands or double up on lower-dose preparations when the higher dose is unavailable.…

The use of insulin biobetters and biosimilars in the UK

An overview of the issues surrounding biosimilar insulins.…

Tirzepatide not recommended for treating type 2 diabetes, says NICE draft guidance

Experts say the news is "disheartening" given the current shortages of GLP-1 receptor agonists.…

Government declares ‘national shortage’ of GLP-1 receptor agonists for type 2 diabetes until 2024

The government attributed the shortages to “an increase in demand for these products for licensed and off-label indications”.…

Metformin may reduce the risk of developing long COVID, research suggests

The diabetes drug reduced the incidence of long COVID compared with placebo, but experts have urged caution over the findings.…

Emotional wellbeing in children and young people with diabetes

Pharmacists can support patients with type 1 diabetes mellitus and their families by recognising difficulties in care, promoting emotional wellbeing and using supportive language.…

How a commissioning support unit increased primary care referrals from the Black Country Integrated Care System to the NHS Diabetes Prevention Programme

Between June 2021 and March 2023, NHS Midlands and Lancashire Commissioning Support Unit (MLCSU) were commissioned by the Black Country and West Birmingham Clinical Commissioning Group (subsequently the Black Country Integrated Care System [ICS]) to engage with practices and directly with patients, …

Boots to trial £20 type 2 diabetes screening service

If deemed suitable for screening, patients will undergo a finger prick blood test and receive diagnostic test results within seven minutes.…

Automated device linked with better glycaemic control in type 2 diabetes patients

In a small trial, participants spent more time in the target glucose zone when using the fully automated system than when on standard insulin therapy.…